As of Jul 26, 2024, the HAE stock has a PE ratio of 39.25. The calculation is based on the latest EPS of $2.32 and the stock price of $91.06 per share. An increase of 14% has been observed in the PE ratio compared to its average of 34.5 of the last four quarters.
The mean historical PE ratio of Haemonetics over the last ten years is 112.36. The current 39.25 P/E ratio is 65% lower than the historical average. Looking back at the last ten years, HAE's PE ratio peaked in the Sep 2017 quarter at 641, with a price of $44.87 and an EPS of $0.07. The Jul 2023 quarter marked the lowest point at 31.65, with a price of $85.14 and an EPS of $2.69.
Maximum annual increase: 183.71% in 2015
Maximum annual decrease: -51.48% in 2023
| Year | PE ratio | Change |
|---|---|---|
| 2024 | 36.79 | 0.93% |
| 2023 | 36.45 | -51.48% |
| 2022 | 75.12 | 5.27% |
| 2021 | 71.36 | 6.75% |
| 2020 | 66.85 | -18.24% |
| 2019 | 81.76 | -3.89% |
| 2018 | 85.07 | N/A |
| 2017 | N/A | N/A |
| 2016 | N/A | N/A |
| 2015 | 133.97 | 183.71% |
The current PE ratio of HAE is lower than its 3, 5 and 10-year averages.
In comparison to its peer BDX, HAE's PE ratio is lower, but it is higher than JNJ's and TMO's. Haemonetics's PE ratio is trading above the peer average of 29.05.
| Stock name | PE ratio | Market cap |
|---|---|---|
| BAX Baxter International Inc | 6.79 | $18.1B |
| JNJ Johnson & Johnson | 10.55 | $386.7B |
| MDT Medtronic plc | 28.41 | $100.91B |
| SYK Stryker Corp | 37.48 | $126.35B |
| TMO Thermo Fisher Scientific Inc | 38.79 | $231.76B |
| HAE Haemonetics Corp | 39.25 | $4.63B |
| BDX Becton Dickinson & Co | 52.27 | $68.58B |
| CERS Cerus Corp | N/A | $440.04M |
As of Jul 26, 2024, HAE stock has a price to earnings ratio of 39.25.
The 3-year average price to earnings ratio for HAE stock is 57.08.
The 5-year average price to earnings ratio for HAE stock is 59.39.
Over the last ten years, the quarterly PE ratio reached its highest level at 641 in the Sep 2017 quarter.
HAE's current price to earnings ratio is 65% below its 10-year historical average.
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Jul 26, 2024), Haemonetics's share price is $91.06. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $2.32. Therefore, Haemonetics's PE ratio for today is 39.25. PE RATIO(39.25) = STOCK PRICE($91.06) / TTM EPS($2.32)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.